Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Freshpet Stock: Leading the Pack with Solid Earnings Results
Freshpet Stock: Leading the Pack with Solid Earnings Results

Freshpet (NASDAQ: FRPT) is a well-known refrigerated pet food products company. Freshpet’s earnings for Q4 2023 and FY 2023 have caught market attention, sending the stock up over 15% . This surge

Insider selling at JPM: A Closer Look Amidst Historic CEO Sale
Insider selling at JPM: A Closer Look Amidst Historic CEO Sale

The recent insider selling activity at JPMorgan Chase & Co. (NYSE: JPM), a leading banking and financial institution, has drawn notable attention, with CEO Jamie Dimon making his first-ever stock

Insider selling at JPM: A Closer Look Amidst Historic CEO Sale
Insider selling at JPM: A Closer Look Amidst Historic CEO Sale

The recent insider selling activity at JPMorgan Chase & Co. (NYSE: JPM), a leading banking and financial institution, has drawn notable attention, with CEO Jamie Dimon making his first-ever stock

Workday Stock Price is Working on a Buy-the-Dip Opportunity
Workday Stock Price is Working on a Buy-the-Dip Opportunity

Workday, Inc. (NASDAQ: WDAY) issued a lackluster FQ2 report that left the market wishing for more. However, as tepid as the results are, underperformance is relative to analysts' consensus

Palantir Stock Has It all… Except the Analysts' Support
Palantir Stock Has It all… Except the Analysts' Support

Palantir Technologies (NYSE: PLTR) stock is gaining traction and may advance another 50% or more in the next few months. The company has a solid product, growing demand, deepening penetration and

Palantir Stock Has It all… Except the Analysts' Support
Palantir Stock Has It all… Except the Analysts' Support

Palantir Technologies (NYSE: PLTR) stock is gaining traction and may advance another 50% or more in the next few months. The company has a solid product, growing demand, deepening penetration and

Palantir Stock Has It all… Except the Analysts' Support
Palantir Stock Has It all… Except the Analysts' Support

Palantir Technologies (NYSE: PLTR) stock is gaining traction and may advance another 50% or more in the next few months. The company has a solid product, growing demand, deepening penetration and

3 wealth-compounding stocks to beat the market this decade
3 wealth-compounding stocks to beat the market this decade

Because the Federal Reserve (the Fed) has announced potential interest rate cuts for this year, an expectation priced in for March is now being pushed as far back as May or June, according to the 

Eilt: Sensationelle Krypto-Übernahme - Massives Kaufsignal. Diese Krypto-Aktie jetzt kaufen. Neuer 421% Crypto Hot Stock nach 5.544% mit Ethereum ($ETH) und 1.337.328% mit Bitcoin ($BTC)
Eilt: Sensationelle Krypto-Übernahme - Massives Kaufsignal. Diese Krypto-Aktie jetzt kaufen. Neuer 421% Crypto Hot Stock nach 5.544% mit Ethereum ($ETH) und 1.337.328% mit Bitcoin ($BTC)

Eilt: Sensationelle Krypto-Übernahme - Massives Kaufsignal. 421% Crypto Hot Stock nach 1.337.328% mit Bitcoin ($BTC)

 

28.02.24 08:18

AC Research

 

Vancouver (www.aktiencheck.de, Anzeige)

 

Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 525% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 525% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. 525% Biotech Hot Stock nach 9.290% mit Novo-Nordisk

 

28.02.24 08:03

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 525% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 525% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. 525% Biotech Hot Stock nach 9.290% mit Novo-Nordisk

 

28.02.24 08:03

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 525% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 525% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. 525% Biotech Hot Stock nach 9.290% mit Novo-Nordisk

 

28.02.24 08:03

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Autozone stock price is still in the rally zone
Autozone stock price is still in the rally zone

Autozone (NYSE: AZO) shares surged following the FQ2 report, confirming the uptrend is intact. Because the news aligns with the outlook for growth and capital returns, the trend will likely

Westward Gold Outlines 2024 Exploration Goals at Cortez Trend Properties
Westward Gold Outlines 2024 Exploration Goals at Cortez Trend Properties

Vancouver, British Columbia, February 27, 2024 – Westward Gold Inc. (CSE: WG, OTCQB: WGLIF, FSE: IM50) (“Westward” or the “Company”) is pleased to provide preliminary details surrounding

New highs are coming for Lowe’s stock despite mixed results
New highs are coming for Lowe’s stock despite mixed results

At face value, Lowe’s Companies (NYSE: LOW) had a rough Q4 compared to competitor Home Depot, but the details within the report belie that assessment. Comps were weak, but the company is building

3 lithium stocks to ride a multi-year cycle
3 lithium stocks to ride a multi-year cycle

The world used to run on coal and other types of fuel that powered the different titans of industry. This cycle started with transportation through railways to factories and steel mills that were

Domino's Q4 2023 report: Hot and fresh or cold and crusty?
Domino's Q4 2023 report: Hot and fresh or cold and crusty?

Domino's Pizza Inc. (NYSE: DPZ) is a globally recognized pizza delivery brand recently gaining noteworthy attention. Domino's financial results for the fourth quarter of 2023 were reported, and

Goldman upgraded Nvidia stock, one metric says it could go higher
Goldman upgraded Nvidia stock, one metric says it could go higher

Today's market seems to be all over the hype stories found in the world of technology stocks. This is especially the case with blowout performances by names like Nvidia Corporation (NASDAQ: NVDA)

Goldman upgraded Nvidia stock, one metric says it could go higher
Goldman upgraded Nvidia stock, one metric says it could go higher

Today's market seems to be all over the hype stories found in the world of technology stocks. This is especially the case with blowout performances by names like Nvidia Corporation (NASDAQ: NVDA)

Goldman upgraded Nvidia stock, one metric says it could go higher
Goldman upgraded Nvidia stock, one metric says it could go higher

Today's market seems to be all over the hype stories found in the world of technology stocks. This is especially the case with blowout performances by names like Nvidia Corporation (NASDAQ: NVDA)

Quad/Graphics is a benefactor of the advertising rebound
Quad/Graphics is a benefactor of the advertising rebound

Quad/Graphics Inc. (NYSE: QUAD) is a global full-service marketing solutions firm for commercial clients in the retail, healthcare, financial services, publishing and consumer packaging

bluebird bio: How to play LEAPS options for growth and income
bluebird bio: How to play LEAPS options for growth and income

Gene-editing is making huge headlines in the medical sector stemming from the first FDA approval for a CRISPR/cas9 treatment for sickle cell disease SCD and TDT from CRISPR Therapeutics AG

bluebird bio: How to play LEAPS options for growth and income
bluebird bio: How to play LEAPS options for growth and income

Gene-editing is making huge headlines in the medical sector stemming from the first FDA approval for a CRISPR/cas9 treatment for sickle cell disease SCD and TDT from CRISPR Therapeutics AG

bluebird bio: How to play LEAPS options for growth and income
bluebird bio: How to play LEAPS options for growth and income

Gene-editing is making huge headlines in the medical sector stemming from the first FDA approval for a CRISPR/cas9 treatment for sickle cell disease SCD and TDT from CRISPR Therapeutics AG

Thinking long-term? Don't lose interest in Pinterest
Thinking long-term? Don't lose interest in Pinterest

Pinterest Inc. (NYSE: PINS) stock suffered a 12% sell-off on its Q4 2023 earnings report. The main reason for the selling was a miss on the top line, as revenues failed to beat consensus analyst